LAUREN INDORF: Open Payments
NPI 1659883395 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $150 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| SpringWorks Therapeutics, Inc. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $30 |
| GENZYME CORPORATION | 1 | $23 |
Products named: Enhertu, CALQUENCE, OGSIVEO, Vyloy, SARCLISA.
Industry payments across NY — which companies pay providers there.
